Montelukast for Prevention & Treatment of OHSS

• Status: Unknown status
• Trial end date: 2019-12-01

Summary

montelukast & dydrgesteron will be given to cases with suspected or proven ovarian hyperstimulation in one group in comparison with dydrogesteron alone in the other group.

• Phase: Phase 2

Details

• Lead Sponsor: Benha University
• Collaborator: Hawaa Fertility Center
• Treatments: Montelukast; Progesterone